Find uplifting stories about heroes, innovations, and solutions
4080 results for "muscle therapy"
Children and adults with spinal muscular atrophy now have access to a groundbreaking treatment that targets muscle function directly. The new monthly infusion therapy marks the first of its kind after decades of dedicated research.
Scientists created a breakthrough treatment that successfully restored missing muscle protein in models of Duchenne muscular dystrophy, dramatically improving strength and endurance without the dangerous side effects of current therapies. The new approach could transform treatment for rare genetic disorders and beyond.
A groundbreaking RNA therapy just succeeded in early trials for a rare muscular dystrophy affecting thousands, and it could become the first treatment that actually modifies the disease's progression. Novartis's del-brax showed clear signs of reducing muscle damage in patients with facioscapulohumeral muscular dystrophy.
Patients with a debilitating muscle disease saw symptoms nearly disappear after just six weeks of treatment—and the relief lasted a full year. The breakthrough could transform care for multiple autoimmune conditions.
A nonprofit and patient foundation just committed $7.65 million to develop a gene therapy for a rare muscular dystrophy with no current treatments. The partnership will take the therapy from initial design all the way to human clinical trials.
A groundbreaking treatment that switches off a faulty gene is showing early success in 12 people with a rare form of muscular dystrophy. Instead of losing muscle as expected, patients are gaining strength.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
A safer gene therapy for Duchenne muscular dystrophy just hit a major milestone, bringing hope to families facing this fatal muscle disease. The treatment could offer a better option than current therapies linked to serious side effects.
A gene therapy called ELEVIDYS is helping young boys with Duchenne muscular dystrophy maintain their ability to walk, run, and stand years after a single treatment. Three years after receiving the therapy, treated children showed 70% less decline in muscle function compared to untreated children.
A groundbreaking cell therapy has successfully treated stiff person syndrome, a rare neurological disorder that causes severe muscle stiffness and mobility problems. If approved by the FDA this summer, it would become the first treatment for the condition and the first personalized CAR-T therapy for any autoimmune disease.
Scientists just achieved a major breakthrough in treating two rare muscle diseases that currently have no cure. Early trials show a new delivery method gets medicine directly into muscle cells without serious side effects.
Volunteer therapy dogs are making rounds at WellSpan hospitals, bringing comfort and smiles to patients, families, and healthcare workers during their toughest days. One patient who hadn't spoken in five years after a car accident tried to talk when a therapy dog laid its head on her shoulder.
A therapist noticed runners open up more easily while moving, sparking a growing trend in outdoor therapy sessions. Walk-and-talk therapy combines mental health support with the proven benefits of nature and exercise.
Researchers at Oregon State University developed a new therapy that fights lung cancer tumors while preventing deadly muscle wasting in a single treatment. Early results in mice show the approach works 2.5 times better than standard treatments without harmful side effects.
A new gene therapy for Duchenne muscular dystrophy met its main goal in trials, bringing hope to families facing this devastating disease. The treatment successfully helped 28 of 30 patients produce a crucial muscle protein that could slow disease progression.
A 21-year-old bioengineering student diagnosed with a rare muscle disease at 13 is now engineering a potential cure for herself and nearly 1 million others worldwide. Héloïse Hoffmann just won a $100,000 fellowship to advance her groundbreaking gene therapy research.
A rare muscle disease that once offered families almost no hope now has multiple new treatments helping kids stay stronger longer. Gene therapies and innovative medications are changing what's possible for children with Duchenne Muscular Dystrophy.
Boys with Duchenne muscular dystrophy are showing sustained improvements three years after receiving Elevidys gene therapy, demonstrating the treatment can slow progression of this muscle-wasting disease. The results offer hope to families facing a condition that typically causes rapid physical decline around age 9.
Volunteer therapy dogs are providing emotional support to young patients and their families at Phoenix Children's Hospital. The four-legged visitors help ease anxiety and bring moments of joy during difficult hospital stays.
A breakthrough cancer treatment delivers radiation with pinpoint accuracy, sparing healthy tissue while attacking tumors. The University of Kansas Cancer Center is leading research that could transform how millions receive radiation therapy.
Showing 20 of 4080